Neoleukin Therapeutics

-$0.03 (-2.88%) As of 4:12 PM UTC today

Why Robinhood?

Robinhood gives you the tools you need to put your money in motion. You can buy or sell NLTX and other ETFs, options, and stocks.

About NLTX

Neoleukin Therapeutics, Inc. operates as a biopharmaceutical company, which computational methods to design de novo protein therapeutics. The firm address significant medical needs in oncology, inflammation, and autoimmunity.

CEO
Jonathan G. Drachman
Employees
91
Headquarters
Seattle, Washington
Founded
2003

NLTX Key Statistics

Market cap
42.93M
Price-Earnings ratio
—
Dividend yield
—
Average volume
701.66K
High today
$1.07
Low today
$0.99
Open price
$1.05
Volume
77.22K
52 Week high
$10.00
52 Week low
$0.795

NLTX Earnings

-$0.30
-$0.20
-$0.10
$0.00
Q3 FY20
Q4 FY20
Q1 FY21
Q2 FY21
Q3 FY21
Q4 FY21
Q1 FY22
Q2 FY22
Estimated
— per share
Actual
Expected Aug 4, After Hours
All investments involve risks, including the loss of principal. Securities trading offered through Robinhood Financial LLC, a registered broker-dealer and Member SIPC. Full disclosure